Blood Plasma Market is projected to reach USD 54,787.67 million by 2032, with a CAGR of 7.2% during the forecast period

𝐓𝐡𝐞 𝐛𝐥𝐨𝐨𝐝 𝐩𝐥𝐚𝐬𝐦𝐚 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 𝐔𝐒𝐃 𝟐𝟕,𝟖𝟔𝟏.𝟐𝟓 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟐, 𝐢𝐭 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐢𝐬𝐞 𝐟𝐫𝐨𝐦 𝐚 𝐯𝐚𝐥𝐮𝐞 𝐨𝐟 𝐔𝐒𝐃 𝟐𝟗,𝟒𝟐𝟏.𝟒𝟖 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟑 𝐭𝐨 𝐔𝐒𝐃 𝟓𝟒,𝟕𝟖𝟕.𝟔𝟕 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟐. 𝐓𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐠𝐫𝐨𝐰 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟕.𝟐%. 𝐓𝐡𝐞 𝐯𝐚𝐫𝐢𝐨𝐮𝐬 𝐟𝐚𝐜𝐭𝐨𝐫𝐬 𝐭𝐡𝐚𝐭 𝐚𝐫𝐞 𝐩𝐮𝐬𝐡𝐢𝐧𝐠 𝐭𝐡𝐞 𝐠𝐫𝐨𝐰𝐭𝐡 𝐨𝐟 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞:

• The increasing number of individuals suffering from severe blood disorders, such as thalassemia and hemophilia, is promoting blood plasma market growth.

• The benefits of plasma-derived medicines are becoming more widely known among patients and healthcare professionals, which is eventually increasing market demand.

• The market for blood plasma is growing as new medical indications are being developed for them.

• Market expansion is aided by ongoing research and development to create novel plasma-derived medicines and enhance those that already exist.

𝐖𝐡𝐚𝐭 𝐢𝐬 𝐁𝐥𝐨𝐨𝐝 𝐏𝐥𝐚𝐬𝐦𝐚?
Blood plasma is the liquid part of blood that makes up about 55% of its volume. It's a mixture of water, salts, proteins, fats, and sugars. Plasma's main function is to transport blood cells, nutrients, and waste products throughout the body. Plasma is yellowish and can be stored frozen for about one year. Plasma donations can be used to help people with burns, shock, bleeding disorders, and other conditions. Plasma helps maintain the proper balance of water and electrolytes in the body. Plasma contains proteins like albumin, gamma globulin, and anti-hemophilic factors that help blood clot. Plasma carries waste products from cells to the liver, lungs, and kidneys for excretion. Plasma donations can help replenish blood and plasma lost due to surgery, accidents, or bleeding disorders.

𝐆𝐞𝐭 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.polarismarketresearch.com/industry-analysis/global-blood-plasma-market/request-for-sample

𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐢𝐧 𝐌𝐚𝐫𝐤𝐞𝐭
The presence of multiple competitors is expected to cause competition in the fragmented market. To outperform their rivals and take a sizable portion of the market, these businesses concentrate on strategic tactics like collaboration, product enhancements, and partnerships. A few of the key players are:

• Biotest AG
• CSL
• GC Biopharma Corp
• Grifols
• Intas Pharmaceuticals Ltd
• Kedrion S.p.A.
• LFB
• Octapharma AG
• Sanquin
• Takeda Pharmaceuticals

𝐁𝐥𝐨𝐨𝐝 𝐏𝐥𝐚𝐬𝐦𝐚 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬
• Immunoglobulins dominated with 45.4% revenue share in 2022, serving vital roles in immune responses and treating autoimmune and immunodeficiency disorders.

• Immunodeficiency Diseases segment accounted for 28.7% of revenue in 2022, primarily relying on blood plasma-derived products, like immunoglobulins, to manage various primary immunodeficiency disorders.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐚 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐨𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐁𝐞𝐟𝐨𝐫𝐞 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞:
https://www.polarismarketresearch.com/industry-analysis/global-blood-plasma-market/request-for-discount-pricing

Segmental Breakdown
Blood Plasma, Type Outlook (Revenue - USD Million, 2019 - 2032)
 Albumin
 Factor VIII
 Factor IX
 Immunoglobulin
 Hyperimmune Globulin
 Others

Blood Plasma, Application Outlook (Revenue - USD Million, 2019 - 2032)
 Hemophilia
 Hypogammaglobinemia
 Immunodeficiency Diseases
 Von Willebrand's Disease
 Others

Blood Plasma, End-User Outlook (Revenue - USD Million, 2019 - 2032)
 Hospitals
 Clinics
 Others

The market is primarily segmented based on type, application, end-user, and region.

Based on type, the market for blood plasma is segmented as factor VIII, immunoglobin, factor IX, hyperimmune globulin, albumin, and others.

In 2022, immunoglobulins became a major segment, generating 45.4% of total sales.

Blood plasma market segmentation, based on application, includes hemophilia, hypogammaglobinemia, von Willebrand's disease, immunodeficiency diseases, and others.

In 2022, the immunodeficiency diseases segment held up 28.7% of the total market revenue share.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞:
https://www.polarismarketresearch.com/industry-analysis/global-blood-plasma-market

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞

• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

𝐌𝐨𝐫𝐞 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐋𝐚𝐭𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:
Freeze Drying Equipment Market
https://whatech.com/og/markets-research/medical/923104-freeze-drying-equipment-market-is-projected-to-reach-usd-4-841-75-million-by-2034-with-a-cagr-of-8-7-during-the-forecast-period.html

AI in Drug Discovery Market
https://whatech.com/og/markets-research/medical/923495-ai-in-drug-discovery-market-is-projected-to-reach-35-42-billion-by-2034-exhibiting-a-robust-cagr-of-29-6-during-the-forecast-period.html

Rhinoplasty Market
https://linkewire.com/2025/01/23/rhinoplasty-market-is-expected-to-reach-usd-9-94-billion-by-2028-growing-at-a-cagr-of-6-4/

Surgical Robots Market
https://linkewire.com/2025/01/23/surgical-robot-market-is-projected-to-reach-usd-55-62-billion-by-2034-with-a-cagr-of-16-9/

Dental Service Organization Market
https://www.einpresswire.com/article/775486840/dental-service-organization-market-growing-at-17-4-cagr-to-hit-us-583-68-billion-forecast-by-2032

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

𝐀𝐛𝐨𝐮𝐭 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 & 𝐂𝐨𝐧𝐬𝐮𝐥𝐭𝐢𝐧𝐠, 𝐈𝐧𝐜:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.